JP2004511518A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004511518A5 JP2004511518A5 JP2002535660A JP2002535660A JP2004511518A5 JP 2004511518 A5 JP2004511518 A5 JP 2004511518A5 JP 2002535660 A JP2002535660 A JP 2002535660A JP 2002535660 A JP2002535660 A JP 2002535660A JP 2004511518 A5 JP2004511518 A5 JP 2004511518A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- alkyl
- alkoxy
- substituted
- halogen atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24182500P | 2000-10-19 | 2000-10-19 | |
| PCT/IB2001/001942 WO2002032422A2 (en) | 2000-10-19 | 2001-10-15 | Ep4 receptor inhibitors to treat rheumatoid arthritis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004511518A JP2004511518A (ja) | 2004-04-15 |
| JP2004511518A5 true JP2004511518A5 (https=) | 2005-04-07 |
Family
ID=22912331
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002536282A Expired - Lifetime JP4060182B2 (ja) | 2000-10-19 | 2001-10-15 | 抗炎症剤及び鎮痛剤としてのアリール又はヘテロアリール縮合イミダゾール化合物 |
| JP2002535660A Withdrawn JP2004511518A (ja) | 2000-10-19 | 2001-10-15 | リウマチ様関節炎の治療のためのｅｐ４受容体インヒビター |
| JP2007154590A Expired - Lifetime JP4703607B2 (ja) | 2000-10-19 | 2007-06-11 | 抗炎症剤及び鎮痛剤としてのアリール又はヘテロアリール縮合イミダゾール化合物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002536282A Expired - Lifetime JP4060182B2 (ja) | 2000-10-19 | 2001-10-15 | 抗炎症剤及び鎮痛剤としてのアリール又はヘテロアリール縮合イミダゾール化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007154590A Expired - Lifetime JP4703607B2 (ja) | 2000-10-19 | 2007-06-11 | 抗炎症剤及び鎮痛剤としてのアリール又はヘテロアリール縮合イミダゾール化合物 |
Country Status (50)
Families Citing this family (77)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7544511B2 (en) * | 1996-09-25 | 2009-06-09 | Neuralstem Biopharmaceuticals Ltd. | Stable neural stem cell line methods |
| US7074801B1 (en) * | 2001-04-26 | 2006-07-11 | Eisai Co., Ltd. | Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof |
| AU2003216581A1 (en) * | 2002-04-12 | 2003-10-27 | Pfizer Inc. | Pyrazole compounds as anti-inflammatory and analgesic agents |
| AU2003216579A1 (en) | 2002-04-12 | 2003-10-27 | Pfizer Inc. | Imidazole compounds as anti-inflammatory and analgesic agents |
| CN100579518C (zh) * | 2002-04-12 | 2010-01-13 | 美国辉瑞有限公司 | Ep4受体配体在制备治疗il-6相关疾病的药物中的应用 |
| US8293488B2 (en) | 2002-12-09 | 2012-10-23 | Neuralstem, Inc. | Method for screening neurogenic agents |
| US20040185429A1 (en) | 2002-12-09 | 2004-09-23 | Judith Kelleher-Andersson | Method for discovering neurogenic agents |
| AU2003301184A1 (en) * | 2002-12-20 | 2004-07-22 | Dynogen Pharmaceuticals Inc | METHODS OF TREATING NON-PAINFUL BLADDER DISORDERS USING Alpha2Delta SUBUNIT CALCIUM CHANNEL MODULATORS |
| US7618914B2 (en) * | 2003-02-14 | 2009-11-17 | Wako Pure Chemical Industries, Ltd. | Method for producing hydroxylamine compound using platinum catalyst fixed on ion-exchange resin |
| EP2174932B1 (en) * | 2003-03-13 | 2019-07-03 | Idemitsu Kosan Co., Ltd. | Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same |
| WO2005013902A2 (en) * | 2003-08-04 | 2005-02-17 | Mayo Foundation For Medical Education And Research | Methods and compositions for inhibiting the proliferation of prostate cancer cells |
| FR2860514A1 (fr) * | 2003-10-03 | 2005-04-08 | Sanofi Synthelabo | Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique |
| SI1882946T1 (sl) * | 2003-12-23 | 2010-06-30 | Hoffmann La Roche | Postopek za ugotavljanje revmatoidnega artritisa z merjenjem anti CCP in interlevkina |
| WO2005102389A2 (en) * | 2004-04-20 | 2005-11-03 | Pfizer Products Inc. | Combinations comprising alpha-2-delta ligands and ep4 receptor antagonists |
| US7271271B2 (en) * | 2004-06-28 | 2007-09-18 | Amgen Sf, Llc | Imidazolo-related compounds, compositions and methods for their use |
| EP1814979B1 (en) | 2004-11-17 | 2015-04-08 | Neuralstem, Inc. | Transplantation of human neural cells for treatment of neurodegenerative conditions |
| US7442716B2 (en) | 2004-12-17 | 2008-10-28 | Merck Frosst Canada Ltd. | 2-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitors |
| JP5086809B2 (ja) * | 2004-12-17 | 2012-11-28 | メルク カナダ インコーポレイテッド | ｍＰＧＥＳ−１阻害剤としての２−（フェニルまたはヘテロ環式）−１Ｈ−フェナントロ［９，１０−ｄ］イミダゾール |
| US7534796B2 (en) | 2005-02-18 | 2009-05-19 | Wyeth | Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor |
| US7582634B2 (en) | 2005-02-18 | 2009-09-01 | Wyeth | 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor |
| US7538113B2 (en) | 2005-02-18 | 2009-05-26 | Wyeth | 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor |
| CA2600510C (en) * | 2005-03-11 | 2010-11-02 | Pfizer Inc. | Crystal forms of an imidazole derivative |
| US7531542B2 (en) | 2005-05-18 | 2009-05-12 | Wyeth | Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor |
| US7582636B2 (en) | 2005-05-26 | 2009-09-01 | Wyeth | Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor |
| CA2634699A1 (en) | 2005-12-21 | 2007-06-28 | Decode Genetics Ehf | N-linked aryl heteroaryl inhibitors of lta4h for treating inflammation |
| US20090192158A1 (en) * | 2006-05-02 | 2009-07-30 | Stacia Kargman | Methods for Treating or Preventing Neoplasias |
| CL2007002994A1 (es) * | 2006-10-19 | 2008-02-08 | Wyeth Corp | Compuestos derivados heterociclicos que contienen sulfamoilo, inhibidores de hsp90; composicion farmaceutica; y uso para el tratamiento del cancer, tal como cancer de mama, de colon y prostata, entre otros. |
| CN101636385B (zh) * | 2007-03-26 | 2012-09-05 | 默克弗罗斯特加拿大有限公司 | 作为ep4受体拮抗剂的萘和喹啉磺酰脲衍生物 |
| DE102007037579B4 (de) | 2007-08-09 | 2012-05-16 | Emc Microcollections Gmbh | Neue Benzimidazol-2-yl-alkylamine und ihre Anwendung als mikrobizide Wirkstoffe |
| ES2424214T3 (es) * | 2007-08-27 | 2013-09-30 | Siga Technologies, Inc. | Medicamentos antivirales para el tratamiento de una infección por Arenavirus |
| EP2265581A1 (en) | 2008-01-22 | 2010-12-29 | Oxagen Limited | Compounds having crth2 antagonist activity |
| WO2010034110A1 (en) * | 2008-09-25 | 2010-04-01 | Merck Frosst Canada Ltd. | Beta-carboline sulphonylurea derivatives as ep4 receptor antagonists |
| EP2392323A4 (en) | 2009-01-30 | 2012-09-26 | Univ Kyoto | INHIBITOR OF PROSTATE CANCER PROGRESSION AND METHOD OF INHIBITING PROGRESSION |
| EP2965756B1 (en) | 2009-04-22 | 2018-10-10 | AskAt Inc. | Selective ep4 receptor antagonistic substance for treatment of cancer |
| KR101041561B1 (ko) * | 2009-12-21 | 2011-06-15 | 짚라인코리아 (주) | 비행용 착용복 |
| US9457084B2 (en) * | 2010-02-22 | 2016-10-04 | Raqualia Pharma Inc. | Use of EP4 receptor antagonists in the treatment of IL-23 mediated diseases |
| NZ623207A (en) | 2010-07-28 | 2014-12-24 | Neuralstem Inc | Methods for treating and/or reversing neurodegenerative diseases and/or disorders |
| PE20131343A1 (es) | 2010-09-21 | 2013-11-18 | Eisai Randd Man Co Ltd | Derivados de acido benzoico |
| EP2669271A4 (en) * | 2011-01-25 | 2014-08-13 | Kissei Pharmaceutical | INDOLE DERIVATIVE AND PHARMACEUTICAL ACCEPTABLE SALT THEREOF |
| TW201326154A (zh) * | 2011-11-28 | 2013-07-01 | 拜耳知識產權公司 | 作為ｅｐ２受體拮抗劑之新穎２ｈ－吲唑 |
| UA115576C2 (uk) | 2012-12-06 | 2017-11-27 | Байєр Фарма Акцієнгезелльшафт | Похідні бензимідазолу як антагоністи ер4 |
| CA2907049C (en) | 2013-03-19 | 2021-08-10 | Askat Inc. | Use of ep4 receptor antagonists in the treatment of cartilage disease |
| US10391086B2 (en) | 2013-03-19 | 2019-08-27 | Askat Inc. | Use of EP4 receptor antagonists in the treatment of cartilage disease |
| WO2014153280A1 (en) * | 2013-03-22 | 2014-09-25 | Merck Sharp & Dohme Corp. | 2-pyridyl carboxamide-containing spleen tyrosine kinase (syk) inhibitors |
| PL3040329T3 (pl) * | 2013-08-29 | 2019-04-30 | Kyoto Pharma Ind | Związek aromatyczny i jego zastosowanie w leczeniu chorób związanych z metabolizmem kości |
| TW201607943A (zh) | 2013-12-19 | 2016-03-01 | 拜耳製藥公司 | 作為ｅｐ４配體之新穎苯并咪唑衍生物 |
| CN107759590A (zh) | 2014-03-06 | 2018-03-06 | 阿莱塔纳治疗学股份有限公司 | Grapiprant的结晶形式 |
| US12109218B2 (en) | 2014-12-09 | 2024-10-08 | Aratana Therapeutics, Inc. | Compositions of grapiprant and methods for using the same |
| PT3113774T (pt) | 2014-03-06 | 2022-02-28 | Elanco Animal Health Incorporated | Composições de grapiprant e métodos de utilização das mesmas |
| WO2016064737A1 (en) | 2014-10-20 | 2016-04-28 | Neuralstem, Inc. | Stable neural stem cells comprising an exogenous polynucleotide coding for a growth factor and methods of use thereof |
| EP3319968A1 (en) | 2015-07-06 | 2018-05-16 | Rodin Therapeutics, Inc. | Heterobicyclic n-aminophenyl-amides as inhibitors of histone deacetylase |
| WO2017007756A1 (en) | 2015-07-06 | 2017-01-12 | Rodin Therapeutics, Inc | Hetero-halo inhibitors of histone deacetylase |
| CN105486851A (zh) * | 2015-11-20 | 2016-04-13 | 中国药科大学 | 一种基于荧光共振能量转移技术的前列腺素受体4筛选模型 |
| CR20180323A (es) | 2015-11-20 | 2018-08-06 | Idorsia Pharmaceuticals Ltd | Derivados de indol n-sustituídos como moduladores de los receptores de pge2 |
| US10342785B2 (en) | 2016-11-04 | 2019-07-09 | Askat Inc. | Use of EP4 receptor antagonists for the treatment of NASH-associated liver cancer |
| HUE057849T2 (hu) | 2017-01-11 | 2022-06-28 | Alkermes Inc | Hiszton deacetiláz biciklusos gátlói |
| WO2018162562A1 (en) | 2017-03-10 | 2018-09-13 | Bayer Pharma Aktiengesellschaft | Use of an ep4 antagonist for the treatment of inflammatory pain |
| KR102612140B1 (ko) | 2017-05-18 | 2023-12-08 | 이도르시아 파마슈티컬스 리미티드 | 피리미딘 유도체 |
| PE20191814A1 (es) | 2017-05-18 | 2019-12-27 | Idorsia Pharmaceuticals Ltd | Derivados de pirimidina como moduladores del receptor de pge2 |
| US11839613B2 (en) | 2017-05-18 | 2023-12-12 | Idorsia Pharmaceuticals Ltd | Pyrimidine derivatives as PGE2 receptor modulators |
| TW201900179A (zh) | 2017-05-18 | 2019-01-01 | 瑞士商愛杜西亞製藥有限公司 | 作為pge2受體調節劑之苯并呋喃及苯并噻吩衍生物 |
| TWI768043B (zh) | 2017-05-18 | 2022-06-21 | 瑞士商愛杜西亞製藥有限公司 | N-取代吲哚衍生物 |
| LT3664802T (lt) | 2017-08-07 | 2022-06-27 | Alkermes, Inc. | Bicikliniai histonų deacetilazės inhibitoriai |
| WO2019038156A1 (en) | 2017-08-22 | 2019-02-28 | Bayer Pharma Aktiengesellschaft | USE OF AN EP4 ANTAGONIST FOR THE TREATMENT OF ARTHRITIS |
| RU2659169C1 (ru) * | 2017-10-31 | 2018-06-28 | Федеральное бюджетное учреждение науки "Уфимский научно-исследовательский институт медицины труда и экологии человека" | Способ прогнозирования риска развития иммуноопосредованных заболеваний у работающих в условиях обсеменённости воздуха рабочей зоны условно-патогенными микроорганизмами |
| JP2021522211A (ja) * | 2018-04-16 | 2021-08-30 | アリーズ セラピューティクス， インコーポレイテッド | Ｅｐ４阻害剤およびその使用 |
| US10239885B1 (en) | 2018-06-18 | 2019-03-26 | Avista Pharma Solutions, Inc. | Compound 1-[2-[4-(2-ethyl-6,8-dimethylimidazo[1,2-α]pyrazin-3-yl)phenyl]ethyl]-3-(p-tolylsulfonyl)urea as a prostaglandin EP4 receptor antagonist |
| US20210315909A1 (en) * | 2018-07-11 | 2021-10-14 | Arrys Therapeutics, Inc. | Polymorphic compounds and uses thereof |
| US20210300921A1 (en) * | 2018-07-11 | 2021-09-30 | Arrys Therapeutics, Inc. | Ep4 inhibitors and synthesis thereof |
| MX2021003904A (es) | 2018-10-05 | 2021-10-26 | Annapurna Bio Inc | Compuestos y composiciones para el tratamiento de afecciones asociadas con la actividad del receptor apj. |
| MX2021009251A (es) | 2019-01-30 | 2021-09-21 | Avista Pharma Solutions Inc | Proceso de sintesis y nuevos compuestos intermedios. |
| CA3128024A1 (en) | 2019-01-30 | 2020-08-06 | Avista Pharma Solutions, Inc. | Chemical compounds |
| CN112341446B (zh) * | 2019-08-09 | 2022-06-17 | 成都先导药物开发股份有限公司 | 一种免疫调节剂 |
| US11254675B2 (en) | 2019-08-12 | 2022-02-22 | Cadila Healthcare Limited | Process for preparation of grapiprant |
| WO2021226162A1 (en) | 2020-05-05 | 2021-11-11 | Arrys Therapeutics, Inc. | Ep4 antagonists and their use in the treatment of proliferative diseases |
| US20230390303A1 (en) | 2020-11-13 | 2023-12-07 | Ono Pharmaceutical Co., Ltd. | Cancer treatment by combination of ep4 antagonist and immune checkpoint inhibitor |
| CN116478155B (zh) * | 2022-01-17 | 2025-06-13 | 洛阳惠中兽药有限公司 | 一种格拉匹伦及其中间体的制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8804439D0 (en) * | 1988-02-25 | 1988-03-23 | Pfizer Ltd | Dihydropyridines |
| IL94805A (en) * | 1989-06-28 | 1994-04-12 | Ciba Geigy Ag | (Arylsulfonamido- and pyridyl- or imidazolyl-)-substituted carboxylic acids, processfor their preparation and pharmaceutical compositions containing them |
| GB9009469D0 (en) * | 1990-04-27 | 1990-06-20 | British Bio Technology | Compounds |
| GB9010404D0 (en) * | 1990-05-09 | 1990-06-27 | Pfizer Ltd | Therapeutic agents |
| GB2330307A (en) * | 1998-02-07 | 1999-04-21 | Glaxo Group Ltd | EP4 Receptor antagonists as bone resorption inhibitors |
| EP1071648A2 (en) * | 1998-03-13 | 2001-01-31 | Merck Frosst Canada & Co. | Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| WO2000021542A1 (en) * | 1998-10-15 | 2000-04-20 | Merck & Co., Inc. | Methods for stimulating bone formation |
| JP2002527393A (ja) | 1998-10-15 | 2002-08-27 | メルク エンド カムパニー インコーポレーテッド | 骨吸収阻害方法 |
| JP2000191615A (ja) * | 1998-10-20 | 2000-07-11 | Takeda Chem Ind Ltd | 芳香族アミン誘導体、その製造法および剤 |
| AU775166B2 (en) | 1999-04-22 | 2004-07-22 | H. Lundbeck A/S | Selective NPY (Y5) antagonists |
| YU72201A (sh) | 1999-04-28 | 2005-07-19 | Aventis Pharma Deutschland Gmbh. | Derivati di-aril kiseline kao ppar receptorski ligandi |
| GB0031315D0 (en) | 2000-12-21 | 2001-02-07 | Glaxo Group Ltd | Indole derivatives |
| GB0031302D0 (en) | 2000-12-21 | 2001-01-31 | Glaxo Group Ltd | Napthalene derivatives |
| GB0031295D0 (en) | 2000-12-21 | 2001-01-31 | Glaxo Group Ltd | Naphthalene derivatives |
-
2001
- 2001-10-08 HN HN2001000224A patent/HN2001000224A/es unknown
- 2001-10-15 CA CA002426487A patent/CA2426487A1/en not_active Abandoned
- 2001-10-15 OA OA1200300117A patent/OA12526A/en unknown
- 2001-10-15 JP JP2002536282A patent/JP4060182B2/ja not_active Expired - Lifetime
- 2001-10-15 HU HU0303766A patent/HUP0303766A3/hu unknown
- 2001-10-15 EP EP06110920.3A patent/EP1666480B1/en not_active Expired - Lifetime
- 2001-10-15 CN CNA018199763A patent/CN1477960A/zh active Pending
- 2001-10-15 DE DE60118020T patent/DE60118020T2/de not_active Expired - Lifetime
- 2001-10-15 AU AU2001294122A patent/AU2001294122A1/en not_active Abandoned
- 2001-10-15 CZ CZ20031010A patent/CZ20031010A3/cs unknown
- 2001-10-15 AT AT01978702T patent/ATE320428T1/de not_active IP Right Cessation
- 2001-10-15 OA OA1200300110A patent/OA12523A/en unknown
- 2001-10-15 PT PT01978702T patent/PT1326864E/pt unknown
- 2001-10-15 WO PCT/IB2001/001940 patent/WO2002032900A2/en not_active Ceased
- 2001-10-15 KR KR10-2003-7005477A patent/KR20030048060A/ko not_active Ceased
- 2001-10-15 HU HU0600593A patent/HUP0600593A3/hu unknown
- 2001-10-15 BR BR0114758-7A patent/BR0114758A/pt not_active IP Right Cessation
- 2001-10-15 MX MXPA03003463A patent/MXPA03003463A/es active IP Right Grant
- 2001-10-15 EE EEP200300190A patent/EE200300190A/xx unknown
- 2001-10-15 YU YU31303A patent/YU31303A/sh unknown
- 2001-10-15 EA EA200300391A patent/EA005991B1/ru not_active IP Right Cessation
- 2001-10-15 AP APAP/P/2001/002299A patent/AP2001002299A0/en unknown
- 2001-10-15 AU AU2002210796A patent/AU2002210796B8/en not_active Ceased
- 2001-10-15 US US09/977,761 patent/US20020077329A1/en not_active Abandoned
- 2001-10-15 CN CNA018192858A patent/CN1476448A/zh active Pending
- 2001-10-15 EP EP01974609A patent/EP1326606A2/en not_active Withdrawn
- 2001-10-15 GE GE5160A patent/GEP20053673B/en unknown
- 2001-10-15 ES ES06110920.3T patent/ES2524586T3/es not_active Expired - Lifetime
- 2001-10-15 CA CA002426457A patent/CA2426457C/en not_active Expired - Lifetime
- 2001-10-15 HR HR20030269A patent/HRP20030269A2/hr not_active Application Discontinuation
- 2001-10-15 IL IL15543801A patent/IL155438A0/xx unknown
- 2001-10-15 JP JP2002535660A patent/JP2004511518A/ja not_active Withdrawn
- 2001-10-15 UA UA2003043568A patent/UA74391C2/uk unknown
- 2001-10-15 AP APAP/P/2003/002806A patent/AP2003002806A0/en unknown
- 2001-10-15 US US09/977,621 patent/US6710054B2/en not_active Expired - Lifetime
- 2001-10-15 DK DK01978702T patent/DK1326864T3/da active
- 2001-10-15 NZ NZ525163A patent/NZ525163A/en unknown
- 2001-10-15 AU AU1079602A patent/AU1079602A/xx active Pending
- 2001-10-15 CZ CZ2003979A patent/CZ2003979A3/cs unknown
- 2001-10-15 SK SK443-2003A patent/SK4432003A3/sk not_active Application Discontinuation
- 2001-10-15 MX MXPA03003448A patent/MXPA03003448A/es unknown
- 2001-10-15 PL PL01365781A patent/PL365781A1/xx not_active Application Discontinuation
- 2001-10-15 EA EA200300387A patent/EA200300387A1/ru unknown
- 2001-10-15 CN CN201010279474.6A patent/CN101967146B/zh not_active Expired - Lifetime
- 2001-10-15 ES ES01978702T patent/ES2258554T3/es not_active Expired - Lifetime
- 2001-10-15 DZ DZ013513A patent/DZ3513A1/fr active
- 2001-10-15 BR BRPI0114704A patent/BRPI0114704B8/pt not_active IP Right Cessation
- 2001-10-15 SK SK460-2003A patent/SK4602003A3/sk not_active Application Discontinuation
- 2001-10-15 EP EP01978702A patent/EP1326864B1/en not_active Expired - Lifetime
- 2001-10-15 IL IL15543901A patent/IL155439A0/xx unknown
- 2001-10-15 SI SI200130519T patent/SI1326864T1/sl unknown
- 2001-10-15 PL PL01362171A patent/PL362171A1/xx not_active Application Discontinuation
- 2001-10-15 KR KR1020037005443A patent/KR100582319B1/ko not_active Expired - Lifetime
- 2001-10-15 WO PCT/IB2001/001942 patent/WO2002032422A2/en not_active Ceased
- 2001-10-15 EE EEP200300188A patent/EE200300188A/xx unknown
- 2001-10-17 AR ARP010104879A patent/AR035498A1/es not_active Application Discontinuation
- 2001-10-17 PE PE2001001031A patent/PE20020548A1/es not_active Application Discontinuation
- 2001-10-17 PY PY200100125983A patent/PY0125983A/es unknown
- 2001-10-18 TW TW095141488A patent/TW200716100A/zh unknown
- 2001-10-18 TN TNTNSN01145A patent/TNSN01145A1/fr unknown
- 2001-10-18 TW TW090125805A patent/TWI294424B/zh active
- 2001-10-18 SV SV2001000696A patent/SV2002000696A/es unknown
- 2001-10-19 PA PA20018531001A patent/PA8531001A1/es unknown
- 2001-10-19 GT GT200100211AK patent/GT200100211AA/es unknown
- 2001-10-19 UY UY26977A patent/UY26977A1/es not_active Application Discontinuation
- 2001-10-19 GT GT200100211A patent/GT200100211A/es unknown
- 2001-11-18 DO DO2001000271A patent/DOP2001000271A/es unknown
-
2003
- 2003-03-31 IS IS6765A patent/IS6765A/is unknown
- 2003-04-03 BG BG107699A patent/BG107699A/bg unknown
- 2003-04-04 CR CR6951A patent/CR6951A/es not_active Application Discontinuation
- 2003-04-08 NO NO20031582A patent/NO20031582L/no not_active Application Discontinuation
- 2003-04-08 ZA ZA200302722A patent/ZA200302722B/en unknown
- 2003-04-08 MA MA27097A patent/MA26952A1/fr unknown
- 2003-04-10 NO NO20031658A patent/NO20031658L/no not_active Application Discontinuation
- 2003-04-10 CR CR6955A patent/CR6955A/es not_active Application Discontinuation
- 2003-04-14 IS IS6785A patent/IS6785A/is unknown
- 2003-04-15 MA MA27107A patent/MA26955A1/fr unknown
- 2003-04-16 EC EC2003004563A patent/ECSP034563A/es unknown
- 2003-04-16 ZA ZA200302991A patent/ZA200302991B/en unknown
- 2003-04-16 BG BG107732A patent/BG107732A/bg unknown
- 2003-04-24 EC EC2003004569A patent/ECSP034569A/es unknown
-
2004
- 2004-02-04 US US10/771,696 patent/US7141580B2/en not_active Expired - Lifetime
-
2006
- 2006-03-30 CY CY20061100447T patent/CY1105035T1/el unknown
- 2006-11-03 US US11/556,523 patent/US7479564B2/en not_active Expired - Lifetime
-
2007
- 2007-06-11 JP JP2007154590A patent/JP4703607B2/ja not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004511518A5 (https=) | ||
| CA3032996C (en) | FORMULATION FOR THE INHIBITION OF 5-HT2B AGONISTS AND METHODS FOR THEIR USE | |
| KR101780666B1 (ko) | Ｉｌ-23 매개 질환의 치료에서 ｅｐ4 수용체 길항제의 용도 | |
| ES2476368T3 (es) | Tratamiento de la artritis reumatoide con una combinación de laquinimod y metotrexato | |
| AU2019416117A1 (en) | CSF1R inhibitors for use in treating cancer | |
| US20210346527A1 (en) | Combination Therapy | |
| ES2565519T3 (es) | Antagonista del receptor de angiotensina II para el tratamiento de la enfermedad cardiovascular en gatos | |
| JP2014532647A5 (https=) | ||
| KR20120089250A (ko) | Ｃｋ２ 조절자로 복합 요법 | |
| US9468612B2 (en) | Cysteamine in the treatment of fibrotic disease | |
| EP2335732A3 (en) | Multiple-variable dose regimen for treating TNF-alpha-related disorders | |
| WO2006014381A3 (en) | Use of thioflavin radiolabeled derivatives in amyloid imaging gor assessing anti-amyloid therapies | |
| JP2006514003A5 (https=) | ||
| RU2007124492A (ru) | Комбинации, включающие эпотилоны и ингибиторы протеинтирозинкиназы, и их фармацевтическое применение | |
| JP2023528722A (ja) | サイトカインストーム症候群及び関連疾患を治療する方法 | |
| RU2012146874A (ru) | Производные пиразолопиридина | |
| Murren et al. | Dose-escalation and pharmacodynamic study of topotecan in combination with cyclophosphamide in patients with refractory cancer. | |
| US20060241037A1 (en) | Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump ihhibitor prodrugs | |
| JP2012516353A (ja) | 血液系悪性腫瘍を治療するための方法及び組成物 | |
| CA2476825A1 (en) | Use of low molecular weight compounds for preparing a medicament useful in treating mutant p53 mediated diseases | |
| US20080207644A1 (en) | Therapeutic materials and methods | |
| RU2010129038A (ru) | Соединения, предназначенные для лечения рака | |
| JP2000516257A5 (https=) | ||
| CN1886157A (zh) | 药物组合 | |
| JP2005525390A5 (https=) |